Categories
Cardiovascular
Diagnostics
Endocrinology
Health Insurance
Medical Devices
Mental Health
Nutrition
Oncology
Public Health
Sexual Health
Popular Articles

New Control System Of The Body Discovered - Important Modulator Of Immune Cell Entry Into The Brain - Perhaps New Target For The Therapy
Researchers in Berlin, Germany have ameliorated inflammation of the brain in mice caused by immune cells. A receptor they discovered on the surface of T cells in the central nervous system (CNS) plays the key role. The researchers showed that this bradykinin receptor 1 (B1) controls the infiltration of immune cells into the CNS. When they activated B1 in mice with encephalitis, they were able to slow down the crossing of the immune cells through the blood-brain-barrier into the CNS. As a result, the inflammation markedly decreased. The work by Dr. Ulf Schulze-Topphoff, Prof. Orhan Aktas, and Professor Frauke Zipp (Cecilie Vogt-Clinic, Charité - Universitätsmedizin Berlin, Max DelbrÃøck Center for Molecular Medicine (MDC) Berlin-Buch and NeuroCure Research Center) together with researchers in Canada and the USA may unveil a new target for the treatment of chronic inflammatory diseases such as multiple sclerosis (MS) (Nature Medicine, doi 10.1038/nm.1980)*.

Mexico Steps Up Efforts To Attract Medical Tourists
Efforts to standardize quality measures for medical tourism are underway as Mexico tries to attract medical tourists. Such efforts come after the swine flu outbreak significantly hurt Mexico"s tourism industry, which ranks third as the country"s of foreign income
News of the day
Pitt School Of Nursing Faculty Inducted Into American Academy Of Nursing
Three faculty members from the University of Pittsburgh School of Nursing will be inducted as fellows into the American Academy of Nursing.
Diagnostics

Gene Variations Can Be Barometer Of Behavior, Choices

Researchers at Brown University and the University of Arizona have determined that variations of three different genes in the brain (called single-nucleotide polymorphisms) may help predict a person"s tendency to make certain choices. By testing DNA samples from saliva in conjunction with computerized cognitive tests, researchers found that the certain gene variations could be connected to certain choices - focusing on decisions that previously produced good outcomes, avoiding negative outcomes, or trying unfamiliar things even though an outcome is uncertain. "In some cases, single genes can have surprisingly strong influences on particular aspects of behavior," said Michael J. Frank, assistant professor of cognitive and linguistic science, psychology, and psychiatry and human behavior. Frank, lead author of the research, directs the Laboratory for Neural Computation and Cognition in the Brown Institute for Brain Science. Frank worked with Brown graduate student Bradley Doll and collaborated with geneticists Francisco Moreno and Jen Oas-Terpstra of the University of Arizona. Research findings will be published in the August 2009 Nature Neuroscience and will be available online July 20. The paper builds on research Frank conducted while he was at the University of Arizona. The study examined the effects of three genes that control aspects of dopamine function in the brain while participants performed a computerized decision-making task. Dopamine is a neurotransmitter that helps keep the central nervous symptom functioning. Its levels fluctuate as the brain feels motivated or rewarded. Varations in two of the genes - DARPP-32 and DRD2 - independently predicted the degree to which people responded to outcomes that were better or worse than expected, by reinforcing approach and avoidance type behaviors. These genes affect dopamine processes in the basal ganglia portion of the brain. Frank said this is important for "simple reinforcement of learning processes that you might not even be aware of." Frank and the other researchers also studied exploratory decision-making - the choices people make when they are in "uncharted territory." They found that variations in a third gene - COMT - predicted the extent to which people explored decisions when they were uncertain whether the decisions might produce better outcomes. COMT affects dopamine levels in the prefrontal cortex, known as an executive center of the brain. Frank said this level might be needed to "prevent the more basic motivational learning system from always taking control over behavior, so as to gather more information and prevent getting stuck in a rut." Frank said the findings could have some interesting implications. "We cannot say on the basis of one or two studies," he said, "but if a student isn"t doing well in a particular learning environment, [a gene study could show that the student] may be well-suited to a particular teaching style." The data could help shape future treatments for conditions such as Parkinson"s disease, which involves dopamine loss. Treatment options now lead to unwanted side effects. "Medications that increase dopamine stimulation can help treat debilitating aspects of the disease but in some patients the meds can induce pathological gambling and impulsivity," he said. Frank suggested that genetic factors involved in influencing motivational processes in the brain could someday help predict which patients would be negatively impacted by particular medications. Seventy-three college students, with a median age of 19, took part in the study. Scientists took saliva samples, from which they extracted DNA and analyzed the genes with subsequent computerized cognitive tests. Subjects watched a clock face, on which the arrow revolved around for five seconds, during which the subjects were to press a button once to try to win points. The subjects did not know that the statistics of their reward depended on their response time, and they had to learn to adjust their responses to increase the number of points they could win. That data was then fed into a biologically based computer model that quantified the learning and exploration processes on a trial-by-trial basis. These variables were then compared against different genes. A grant from the U.S. National Institutes of Mental Health funded the research. Mark Hollmer Brown University


Add your comment:
Name:
Site address: http://
Your message:
Enter today\\\\'s date, 2 digits
(spam protection):

© Copyright 2009